National Health Investors (NYSE:NHI) Hits New 1-Year High After Dividend Announcement

National Health Investors, Inc. (NYSE:NHI) shares reached a new 52-week high during trading on Tuesday after the company announced a dividend. The stock traded as high as $66.10 and last traded at $65.15, with a volume of 113857 shares traded. The stock had previously closed at $64.25.

The newly announced dividend which will be paid on Friday, August 2nd. Shareholders of record on Friday, June 28th will be issued a dividend of $0.90 per share. The ex-dividend date is Friday, June 28th. This represents a $3.60 dividend on an annualized basis and a yield of 5.48%. National Health Investors’s payout ratio is currently 115.02%.

Analyst Ratings Changes

Several research analysts have recently issued reports on NHI shares. BMO Capital Markets upgraded shares of National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 target price for the company in a report on Tuesday, March 12th. Truist Financial raised their price objective on National Health Investors from $55.00 to $58.00 and gave the stock a “hold” rating in a report on Thursday, April 4th. StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Wedbush upped their target price on National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a research report on Monday, March 18th. Finally, Deutsche Bank Aktiengesellschaft began coverage on National Health Investors in a research report on Tuesday, January 30th. They set a “buy” rating and a $69.00 price target on the stock. Five equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $60.50.

National Health Investors Trading Up 2.2 %

The firm has a market cap of $2.85 billion, a price-to-earnings ratio of 20.98 and a beta of 0.95. The business has a 50 day moving average of $60.81 and a 200 day moving average of $56.48. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.90.

Insider Buying and Selling at National Health Investors

In other news, Director Charlotte A. Swafford purchased 10,000 shares of the stock in a transaction dated Tuesday, February 27th. The stock was acquired at an average cost of $58.69 per share, for a total transaction of $586,900.00. Following the completion of the acquisition, the director now directly owns 110,185 shares in the company, valued at approximately $6,466,757.65. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. 8.21% of the stock is owned by insiders.

Hedge Funds Weigh In On National Health Investors

Large investors have recently added to or reduced their stakes in the business. Donoghue Forlines LLC acquired a new position in National Health Investors during the first quarter valued at approximately $354,000. Susquehanna Fundamental Investments LLC purchased a new stake in National Health Investors during the 1st quarter worth $547,000. LSV Asset Management raised its position in National Health Investors by 6.6% in the first quarter. LSV Asset Management now owns 126,700 shares of the real estate investment trust’s stock valued at $7,961,000 after purchasing an additional 7,800 shares during the period. GSA Capital Partners LLP acquired a new position in shares of National Health Investors during the first quarter worth about $484,000. Finally, Daiwa Securities Group Inc. lifted its stake in shares of National Health Investors by 7.2% during the first quarter. Daiwa Securities Group Inc. now owns 14,085 shares of the real estate investment trust’s stock worth $885,000 after purchasing an additional 951 shares in the last quarter. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.